These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9036364)

  • 1. [Low molecular weight heparin: immediate therapy of stroke? A discussion of the study by Kay et al.: Low molecular weight heparin for treatment of acute ischemic stroke].
    Sporer B; Haberl RL
    Nervenarzt; 1996 Oct; 67(10):886-7. PubMed ID: 9036364
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-molecular-weight heparin for the treatment of acute ischemic stroke.
    Kay R; Wong KS; Yu YL; Chan YW; Tsoi TH; Ahuja AT; Chan FL; Fong KY; Law CB; Wong A
    N Engl J Med; 1995 Dec; 333(24):1588-93. PubMed ID: 7477193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the TOPAS trial. Therapy of Patients With Acute Stroke (TOPAS) Investigators.
    Diener HC; Ringelstein EB; von Kummer R; Langohr HD; Bewermeyer H; Landgraf H; Hennerici M; Welzel D; Gräve M; Brom J; Weidinger G
    Stroke; 2001 Jan; 32(1):22-9. PubMed ID: 11136909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of anticoagulants in patients with acute ischemic stroke.
    Counsell C; Sandercock P
    Stroke; 1995 Mar; 26(3):522-3. PubMed ID: 7533952
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin in the treatment of acute stroke.
    Korczyn AD
    Neurol Clin; 1992 Feb; 10(1):209-17. PubMed ID: 1557003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
    Pohl C; Kredteck A; Bastians B; Hanfland P; Klockgether T; Harbrecht U
    Neurology; 2005 Apr; 64(7):1285-7. PubMed ID: 15824368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of heparinoids to treat acute ischemic stroke.
    Carroll VS
    Crit Care Nurs Clin North Am; 1993 Sep; 5(3):525-9. PubMed ID: 8217047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin during acute ischemic stroke. Present data and clinical situation].
    Daffertshofer M; Grips E; Dempfle CE; Hennerici M
    Nervenarzt; 2003 Apr; 74(4):307-19. PubMed ID: 12707700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke.
    Duke RJ; Bloch RF; Turpie AG; Trebilcock R; Bayer N
    Ann Intern Med; 1986 Dec; 105(6):825-8. PubMed ID: 3535601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.
    Donnan GA; Davis SM; Chambers BR; Gates PC; Hankey GJ; McNeil JJ; Rosen D; Stewart-Wynne EG; Tuck RR
    JAMA; 1996 Sep; 276(12):961-6. PubMed ID: 8805730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group.
    Clark WM; Warach SJ; Pettigrew LC; Gammans RE; Sabounjian LA
    Neurology; 1997 Sep; 49(3):671-8. PubMed ID: 9305321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular-weight heparins and heparinoids and their use in acute or progressing ischemic stroke.
    Gordon DL; Linhardt R; Adams HP
    Clin Neuropharmacol; 1990 Dec; 13(6):522-43. PubMed ID: 1703455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparins in the treatment of acute coronary syndromes.
    Turpie AG; Antman EM
    Arch Intern Med; 2001 Jun; 161(12):1484-90. PubMed ID: 11427095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin and early neurologic deterioration in acute stroke caused by large artery occlusive disease.
    Wang Q; Chen C; Chen XY; Han JH; Soo Y; Leung TW; Mok V; Wong KS
    Arch Neurol; 2012 Nov; 69(11):1454-60. PubMed ID: 22893265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low molecular weight heparin, reviparin, after PTCA: results of a randomized double-blind, standard heparin and placebo controlled multicenter study (REDUCE Study].
    Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia E; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R; Karsch KR
    Z Kardiol; 1997 Aug; 86(8):581-91. PubMed ID: 9417748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
    Sandset PM; Dahl T; Stiris M; Rostad B; Scheel B; Abildgaard U
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():25-33. PubMed ID: 1962901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of venous thromboembolism after acute ischaemic stroke.
    Melero MJ; Bergroth B; Contardo DM; Mazzei MM
    Lancet; 2007 Sep; 370(9589):735; author reply 736-7. PubMed ID: 17765510
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind trial of glycerol therapy in early stroke.
    Larsson O; Marinovich N; Barber K
    Lancet; 1976 Apr; 1(7964):832-4. PubMed ID: 56650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P; Carnovali M; Marchiori A;
    Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.